Notable Friday Option Activity: MTSR, CDTX, AI

Cidara Therapeutics (CDTX) and C3.ai (AI) experienced unusually high options trading volume today, significantly exceeding their average daily share volumes. CDTX saw 21,233 contracts, representing 263% of its average daily volume, with notable activity in its November 2025 $110 strike call options. Similarly, AI recorded 85,998 contracts, or 143.6% of its average daily volume, driven by strong interest in its November 2025 $16 strike call options, suggesting heightened speculative interest in both equities.

Analysis

Cidara Therapeutics (CDTX) and C3.ai (AI) experienced significantly elevated options trading volume, indicating heightened speculative interest. CDTX saw 21,233 contracts trade, representing 263% of its average daily share volume, with particular focus on the November 2025 $110 strike call option, which traded 5,723 contracts. Similarly, AI recorded 85,998 contracts, equating to 143.6% of its average daily share volume, driven by 15,605 contracts in the November 2025 $16 strike call.

This surge in long-dated call option activity suggests investors are positioning for substantial upward price movements in both equities over an extended horizon. The concentration in specific strike prices implies targeted directional bets, potentially signaling anticipated future catalysts or a belief in significant long-term growth for these companies within the healthcare/biotech and artificial intelligence sectors, respectively.

Despite the notable options flow, the overall sentiment remains neutral, as the article merely reports the activity without assigning a bullish or bearish interpretation. The substantial volume in these specific calls, however, warrants close observation as it can precede increased equity volatility and potential price discovery.

Key Decisions for Investors

• Investors should monitor the open interest and implied volatility of CDTX and AI options, particularly the November 2025 $110 and $16 call strikes, as these can signal sustained speculative interest and potential future price movements.
• Given the long-dated nature of the active call options, a fundamental review of CDTX's healthcare pipeline and AI's enterprise AI solutions is warranted to identify potential catalysts justifying such bullish long-term positioning.
• Be prepared for potential increased equity volatility in CDTX and AI shares, as high options trading volume, especially in directional calls, often correlates with subsequent price sensitivity and broader market attention.